Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019693 (
HIV
)
170,526
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The virion surface of the human immunodeficiency virus (
HIV
-1) is covered with an envelope glycoprotein gp120. Study of the oligosaccharide structures of gp120 suggests that the high
mannose
type of oligosaccharides are essential for
HIV
-1 infection. Pradimicin A, an antifungal antibiotic isolated from Actinomadura hibisca, and the derivative BMY-28864 have the ability to inhibit
HIV
-1 infection in vitro. The inhibitory effect was suppressed by addition of high
mannose
type oligosaccharides of gp120. BMY-28864 bound directly to gp120,
mannose
-BSA, and neoglycolipids containing high
mannose
type oligosaccharides but not to natural mammalian glycoproteins. The binding was Ca2+ dependent and was inhibited by
mannose
. BMY-28864 is a unique carbohydrate-binding antibiotic which has never been reported. It is possible to block
HIV
-1 infection by targeting oligosaccharide chains of the envelope glycoprotein.
...
PMID:[New anti-HIV drug which binds the oligosaccharides of HIV envelope glycoprotein]. 747 2
The first flavone-xanthone C-
glucoside
, swertifrancheside, was isolated from Swertia franchetiana, and its structure was elucidated on the basis of spectroscopic analysis as 1,5,8-trihydroxy-3-methoxy-7-(5',7',3'',4''- tetrahydroxy-6'-C-beta-D-glucopyranosyl-4'-oxy-8'-flavyl)-xanthone . This compound was a moderately potent inhibitor of
HIV
reverse transcriptase.
...
PMID:Swertifrancheside, an HIV-reverse transcriptase inhibitor and the first flavone-xanthone dimer, from Swertia franchetiana. 751 47
The fundamental role played by reverse transcriptase (RT) in the replication of retroviruses has made this enzyme a key target in the chemotherapy of
HIV infection
. Since the replicative cycle of
HIV
is interrupted by RT inhibitors, the inhibition of
HIV
RT is currently considered as a useful approach in the prophylaxis and intervention of AIDS. The MeOH and water extracts of 41 medicinal plants used in Egyptian folk medicine were evaluated for their
HIV
-1 RT inhibitory effects, and inhibitory substances were identified from the fruit of Phyllanthus emblica that showed a potent inhibitory activity to
HIV
-1-RT. The enzyme activity was determined by the amount of tritium labeled-substrate incorporation into a polymer fraction in the presence of a template-primer. Of the plant materials tested, the fruits of Phyllanthus emblica L. (MeOH extract), Quercus pedunculata (MeOH and water extracts), Rumex cyprius (MeOH and water extracts), Terminalia bellerica (MeOH and water extracts), Terminalia chebula (MeOH and water extracts), and Terminalia horrida (MeOH extract) showed significant inhibitory activity with IC50 of 2-49 mcg/ml. However, in the presence of bovine serum albumin (BSA), the inhibitory potency of most of the extracts, except for P. emblica (MeOH extract) and T. chebula (water extract), was appreciably reduced by nonspecific binding of their ingredients with BSA. Through a bioassay guided-fractionation of the methanol extract of the fruit of P. emblica, putranjivain A (1) was isolated as a potent inhibitory substance with IC50 = 3.9 mcM, together with 1,6-di-O-galloyl-
beta-D-glucose
(2), 1-O-galloyl-
beta-D-glucose
(3), kaempferol-3-O-beta-D-
glucoside
(4), quercetin-3-O-beta-D-
glucoside
(5), and digallic acid (6). The inhibitory mode of action by 1, 2, and 6 was noncompetitive with respect to the substrate but competitive with respect to a template-primer. Furthermore, the stereochemistry of 1 was established in this paper by nuclear magnetic resonance spectroscopy.
...
PMID:Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase. 754 17
Swertifrancheside [1], a new flavonone-xanthone
glucoside
isolated from Swertia franchetiana, 1 beta-hydroxyaleuritolic acid 3-p-hydroxybenzoate [2], a triterpene isolated from the roots of Maprounea africana, and protolichesterinic acid [3], an aliphatic alpha-methylene-gamma-lactone isolated from the lichen Cetraria islandica, were found to be potent inhibitors of the DNA polymerase activity of human immunodeficiency virus-1 reverse transcriptase (
HIV
-1 RT), with 50% inhibitory doses (IC50 values) of 43, 3.7, and 24 microM, respectively. They were not cytotoxic with cultured mammalian cells. The kinetic mechanisms by which compounds 1-3 inhibited
HIV
-1 RT were studied as was their potential to inhibit other nucleic acid polymerases. Swertifrancheside [1] bound to DNA and was shown to be a competitive inhibitor with respect to template-primer, but a mixed-type competitive inhibitor with respect to TTP. On the other hand, 1 beta-hydroxyaleuritolic acid 3-p-hydroxybenzoate [2] and protolichesterinic acid [3] were mixed-type competitive inhibitors with respect to template-primer and noncompetitive inhibitors with respect to TTP. Therefore, the mechanism of action of 1 beta-hydroxyaleuritolic acid 3-p-hydroxybenzoate [2] and protolichesterinic acid [3] as
HIV
-1 RT inhibitors involves nonspecific binding to the enzyme at nonsubstrate binding sites, whereas swertifrancheside [1] inhibits enzyme activity by binding to the template-primer.
...
PMID:Mechanistic evaluation of new plant-derived compounds that inhibit HIV-1 reverse transcriptase. 756 95
The nuclear carbohydrate-binding protein 35 (CBP35), a beta-galactoside-specific lectin with an M(r) of 35,000, has been identified in nuclear ribonucleoprotein complexes (RNPs) from a variety of mammalian tissues and cells. Here we determined that the expression of CBP35 mRNA greatly increases after infection of Molt-3 cells with human immunodeficiency virus type 1 (HIV-1), concomitantly with the onset of expression of the viral regulatory gene tat, and then declines. The increase in CBP35 mRNA level results in an enhanced synthesis of CBP35, as evidenced in nitrocellulose filter binding assay using radiolabeled, sugar-specific neoglycoprotein. Immunoblotting experiments showed that CBP35 is present in the 40S heterogeneous nuclear RNP complex from
HIV
-1-infected Molt-3 cells. CBP35 could also be detected using a novel photoreactive
alpha-D-galactose
probe designed for the specific detection of CBP.
...
PMID:Expression of nuclear lectin carbohydrate-binding protein 35 in human immunodeficiency virus type 1-infected Molt-3 cells. 760 Jan 1
Various sulfated cerebroside analogs, which are mimicks of cerebroside, have been prepared from per-O-acetylated
D-glucose
, per-O-acetylated D-
galactose
, and per-O-acetylated D-lactose with ethyleneglycol dodecyl ether, 3-docosyloxy-1-propanol, 2-hydroxymethyl-1,3-O-dimyristyl-1,3-propanediol, and L-serine diamide derivatives as ceramide moieties. The synthesized sulfated glycolipids showed anti-
HIV
-1 activities.
...
PMID:Synthesis of sulfated cerebroside analogs having mimicks of ceramide and their anti-human immunodeficiency virus type 1 activities. 760 Jun 12
The authors examined change in cerebral metabolic function over time by using PET in
HIV
-infected individuals diagnosed with AIDS. Ten subjects with AIDS received [18F]2-fluoro-2-deoxy-
D-glucose
PET scans and completed a comprehensive neuropsychological battery. The scan and test battery were repeated after 6 months. Over time, the subjects showed increased relative basal ganglia metabolism as well as increased parietal lobe metabolism. There were no statistically significant changes in neuropsychological performance. These results suggest that PET may be more sensitive than traditional neuropsychological evaluation to subtle central nervous system changes in AIDS.
...
PMID:Cerebral metabolic change in patients with AIDS: report of a six-month follow-up using positron-emission tomography. 762 61
The surface of
HIV
-1, like that of other retroviruses, is studied with virally encoded glycoproteins which appear ultrastructurally as electron-dense spikes or knobs. The glycoprotein that forms the spike structure, gp120, is non-covalently bound to the transmembrane glycoprotein gp41. Mature
HIV
-1 virions do not have as many spikes as the genetically related retroviruses
HIV
-2 and SIV. gp120 is lost from
HIV
-1 during viral morphogenesis and after incubation of the virus with the soluble form of cellular receptor CD4. In this study we used ultrastructural cytochemistry and morphometry to quantitate the distribution of envelope glycoprotein spikes on budding and mature
HIV
-1 virions and to look for alternatives to the laborious and somewhat subjective spike-counting technique for envelope spike analysis on
HIV
-1.
HIV
-1, strain HTLV-IIIB, was examined after staining of envelope glycoproteins with either tannic acid, immunogold staining for gp120 (gp120-immunogold), or lectin-gold staining with concanavalin A for
mannose
residues (ConA-HRP-gold) and frequency distributions of spikes or gold particles per micron
HIV
-1 membrane generated. Envelope spikes were normally distributed on membranes of budding and mature
HIV
-1. However, the density of spikes per micron viral membrane on mature
HIV
-1 virions was approximately 50% of that observed on budding virions. ConA-HRP-gold and gp120-immunogold did not efficiently label budding virions. The shape of the frequency distribution for ConA-HRP-gold particles on mature virions was similar to that for envelope spikes and could be used to quantitate envelope glycoproteins on
HIV
-1. In addition, ConA-HRP-gold staining was able to detect the loss of envelope proteins after treatment of virus with soluble CD4. gp120-immunogold labeling was patchy and many virions were unlabeled. ConA-HRP-gold staining proved to be a rapid, reliable, and easily quantifiable method for estimation of envelope glycoprotein density on mature
HIV
-1. However, the loss of spike structures throughout the life cycle of
HIV
-1 can effectively be determined only by direct spike counting.
...
PMID:Morphometric analysis of envelope glycoprotein gp120 distribution on HIV-1 virions. 767 71
Four cases of pulmonary cryptococcosis were diagnosed by cytological detection of Cryptococcus neoformans in bronchial lavage. Three patients had underlying diseases, but not
HIV infection
. The chest X-rays showed 2 patients with nodular lesions and 2 with cavitary lesions. The cryptococcal antigen in the serum was positive in all four patients. In the cytology of bronchial lavage, Cryptococcus neoformans was detected after period-acid-Schiff (PAS) staining and was cultured in Sabouraud-
dextrose
agar. The cytology of bronchial lavage is useful for the rapid diagnosis of pulmonary cryptococcosis.
...
PMID:Detection of Cryptococcus neoformans in bronchial lavage cytology: report of four cases. 771 82
Lectins with specificity for terminal
mannose
residues and anti-mannan antibodies neutralize
HIV
-1 infection in vitro. This is assumed to be caused by binding of the agents to the viral glycoproteins. In this study we show that one such agent, the Galanthus nivalis lectin (GNA), also blocks infection at the target cell level. To explore the effect of GNA on
HIV infection
we used the two
HIV
-1 isolates LAV and NDK, representing in the first case a prototype virus and in the latter case a highly cytopathic virus, which spreads preferentially via cell-to-cell contact. MT-4 cells were used as target cells and infection was determined from the occurrence of syncytia. Cell-to-cell infection was studied with CEM cells persistently infected with the two virus isolates. GNA, at concentrations in the nanogram per milliliter range, neutralized the
HIV
-1 isolates LAV, NDK, and MN as well as
HIV
-2ROD. Pretreatment of cells with the lectin, before addition of virus, or of infected cells, also blocked infection. This effect was more pronounced with
HIV
-1NDK than with
HIV
-1LAV. Mannosidase treatment of the target cells abolished the GNA effect on
HIV
-1NDK infection. It is concluded that GNA inhibits infection of several
HIV
isolates. It neutralizes infection by binding to the virion but also blocks infection at the target cell level. The latter effect may be different for different virus isolates. Mannosyl residuals at the cell surface are targets for GNA modulation of infection with the cytopathic
HIV
-1NDK. These do not represent essential virus receptors.
...
PMID:Lectin-mediated effects on HIV type 1 infection in vitro. 773
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>